Literature DB >> 12923392

Hypertension, matrix metalloproteinases and target organ damage.

Richard Donnelly, Deborah J Collinson, Gillian Manning.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12923392     DOI: 10.1097/00004872-200309000-00009

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


× No keyword cloud information.
  6 in total

Review 1.  Matrix metalloproteinases, atherosclerosis, proteinuria and kidney disease: Linkage-based approaches.

Authors:  G Dimas; F Iliadis; D Grekas
Journal:  Hippokratia       Date:  2013-10       Impact factor: 0.471

2.  Urinary Markers of Podocyte Dysfunction in Chronic Glomerulonephritis.

Authors:  Natalia Chebotareva; Irina Bobkova; Lidia Lysenko; Sergey Moiseev
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  The Molecular Aspect of Nephrolithiasis Development.

Authors:  Paulina Wigner; Radosław Grębowski; Michal Bijak; Janusz Szemraj; Joanna Saluk-Bijak
Journal:  Cells       Date:  2021-07-29       Impact factor: 6.600

Review 4.  Matrix metalloproteinases as drug targets in preeclampsia.

Authors:  Ana C T Palei; Joey P Granger; Jose E Tanus-Santos
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

5.  Anti-Renal Fibrotic Effect of Exercise Training in Hypertension.

Authors:  Ching Huang; Yi-Yuan Lin; Ai-Lun Yang; Tang-Wei Kuo; Chia-Hua Kuo; Shin-Da Lee
Journal:  Int J Mol Sci       Date:  2018-02-20       Impact factor: 5.923

Review 6.  Matrix Metalloproteinases and Hypertension-Mediated Organ Damage: Current Insights.

Authors:  Valeria Bisogni; Alberto Cerasari; Giacomo Pucci; Gaetano Vaudo
Journal:  Integr Blood Press Control       Date:  2020-11-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.